Connect with us

COVID-19

COVID-19: We believe in Hydroxychroloquine- Director of NAFDAC

Published

on

clinical Adeyeye NAFDAC COVID-19 Hydroxychloroquine

COVID-19: We believe in Hydroxychroloquine- Director of NAFDAC

The Director of National Agency for Food and Drug Administration and Control (NAFDAC), Adeyeye Mojisola, said this. Nigerians go on with Hydroxychloroquine clinical trials to cure COVID-19.

Despite the warning by the World Health Organization (WHO), Nigeria authorities have said that they will continue with hydroxychloroquine clinical trials on COVID-19 patients.

”I do not know the data that they’re looking at, whether it’s from the Caucasian population or from the African population,” the director of Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) said.

”If the data they’re looking at and the reason for suspending the trials is from the Caucasian population, then it may be justified. But I don’t think we have data from the African population yet because our genetic makeup is different,” Mojisola Adeyeye was quoted by local media as saying on Tuesday.

”If medical doctors, research scientists, pharmacists, herbal experts work together, we should conclude the clinical trial in 3-4 months. The narrative might change afterward but for now, we believe in hydroxychloroquine,” she added.

On Monday, the WHO said that due to safety concerns, it is temporarily halting a clinical trial of the anti-malaria drug hydroxychloroquine for treating coronavirus patients.

ALSO READ: 

The announcement followed a publication by the Lancet medical journal of an observational study on hydroxychloroquine and chloroquine and its effects on hospitalized COVID-19 patients.

More than 400 hospitals in 35 countries are actively recruiting patients, and nearly 3,500 patients had been enrolled from 17 countries to test the drug, according to the WHO.

Nigeria has so far recorded 8,344 coronavirus cases, with 249 deaths, and 2,385 recoveries, according to the Africa Centers for Disease Control and Prevention.

The pandemic has claimed more than 350,500 lives in 188 countries and regions since originating in China last December. The US and Brazil are currently the worst-hit countries.

More than 5.59 million cases have been reported worldwide and 2.28 million people have recovered to date, according to figures compiled by the US-based Johns Hopkins University.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

COVID-19

Nigeria to Receive 3.92 Million Doses of Covid-19 Vaccine in July

Published

on

Nigeria to Receive 3.92 Million Doses of Covid-19 Vaccine in July

Nigeria’s Government on Tuesday said it is expecting a shipment of 3.92 million doses of the Oxford-AstraZeneca vaccine by end of July or early August.

Speaking during a press conference in Abuja, the Executive Director, National Primary Healthcare Development Agency (NPHCDA), Faisal Shuaib, said, “we now have information that Nigeria will get 3.92m doses of Oxford-AstraZeneca by end of July or early August”.

As we receive additional information on the exact dates in August, we will provide an update regarding timelines and details, he said.

YOU CAN FOLLOW US ON FACEBOOK

While working with Nigeria’s international partners to confirm the next shipment of vaccines to Nigeria, Shuaib stated that the federal government has commenced administering the first dose of the vaccine which was earlier halted due to shortages of vaccines.

Shuaib further added that the goal of government is to do everything possible to educate, combat misinformation and engender confidence in the safety and effectiveness of vaccines and ensure all Nigerians have clear information on how, where, and when to get the vaccine.

Read Also:

FG Flags Off Construction of Farin-Ruwa Multipurpose Dam

Vaccines Effective Against Variants but Overseas Travel Still Not Safe Says WHO

Continue Reading

COVID-19

COVID-19: NCAA Issues Guidelines to In-Flight Catering Services

Published

on

COVID-19: NCAA Issues Guidelines to In-Flight Catering Services

The Nigerian civil aviation authority has issued guidelines for companies providing in-flight catering services to airlines operating domestic flights in Nigeria.

In a circular issued by the NCAA on its website on the resumption of domestic flight operations in the country, in-flight catering companies are required by the authority to carry out regular risk assessments of their operations, and put in place remedial actions to address any identified hazard to prevent the possible spread of Covid-19 virus to their customers through their products.

YOU CAN FOLLOW US ON FACEBOOK

According to the circular, domestic airlines will only serve pre-packed catering products in sealed containers to their passengers during disembarkation while catering products won’t be served or consumed in-flight by airlines or passengers respectively on any domestic flight.

It further urged all domestic airlines to comply with its directives in other to help curb the spread of the coronavirus disease.

Read Also: FG designates 4 international airports special economic zones

Continue Reading

COVID-19

EU to Ditch J&J Covid-19 Vaccines from U.S Factory After Contamination Reports

Published

on

EU to Ditch J&J Covid-19 Vaccines from U.S Factory After Contamination Reports

Europe’s drug regulator said on Friday that batches of Johnson & Johnson’s covid-19 vaccine made for the region around the time when contamination issues were revealed at a U.S. manufacturing site would not be used.

The announcement came in the wake of reports, which said the U.S. Food & Drug Administration had asked Johnson & Johnson to discard 60 million doses of its COVID-19 vaccine that were manufactured at the troubled Baltimore factory.

The European Medicines Agency (EMA) said it was aware a batch of the active substance for J&J’s Covid-19 vaccine had been contaminated in April, with materials for another vaccine made at the site in Maryland owned by Emergent Bio solutions.

YOU CAN FOLLOW US ON FACEBOOK

The production of J&J’s vaccine at the site was halted by U.S. authorities and J&J was put in charge of manufacturing at the plant.

The April error involved ingredients from AstraZeneca’s covid-19 vaccine, also being produced at the plant, contaminating a batch of J&J’s vaccine, developed by its Janssen unit.

However, EMA said the batches of the vaccine released in the region had not been affected by the cross contamination, based on the information it has.

Read Also:

Biden Reinstates U.S Covid-19 Travel Restrictions

J&J to Distribute up to 400 million COVID-19 Vaccines to Africa

Continue Reading
COVID-19 PREVENTION

infectious diseases in your community. It is very important to wash your hand frequently with soap under running water.

COVID-19 IS REAL

#COVID19NIGERIA Situation Report

The #COVID19Nigeria situation report for 21st July, 2020 has been published. Our daily reports provide a summary of the epidemiological situation & response activities in Nigeria

The #COVID19Nigeria situation report for 21st July, 2020 has been published. Our daily reports provide a summary of the epidemiological situation & response activities in Nigeria

@Africa CDC

The African Union and Africa CDC will virtually rollout the Partnership to Accelerate COVID-19 Testing (PACT) in Africa tomorrow 4 June, 2020 at 11.00 am Eastern Africa Time.

The African Union and Africa CDC will virtually rollout the Partnership to Accelerate COVID-19 Testing (PACT) in Africa tomorrow 4 June, 2020 at 11.00 am Eastern Africa Time.

GALLANT OFFICER

Gallant Officer
"Also found worthy of honour was Bashir Abubakar, an Asst Comptroller-General of Customs, who rejected a bribe of $412,000 per container offered him by drug traffickers seeking to bring 40 containers of Tramadol into Nigeria. A fine example of incorruptibility, worthy of emulation"

Trending